title: Evolved tumor suppression: why are we so good at not getting cancer?
abstract: The law of natural selection can be used to understand cancer development at the level of species as well as at the level of cells and tissues. Through this perspective, I seek to explain: (i) Why the lack of sufficient selective pressure to prevent cancers in old age helps explain the exponential increase in cancer incidence in the elderly. (ii) Why the evolution of long-lived animals necessitated the acquisition of potent tumor suppressive mechanisms. (iii) How the requirement to prevent inappropriate somatic cell expansion and cancer has constrained developmental and tissue architectural modalities. (iv) How the evolution of well-adapted stem cells with complex niche requirements has conferred resistance to oncogenic mutations, as phenotype-altering genetic change is almost always disadvantageous within a well-adapted cell population. (v) How the impairment of stem cell fitness, as occurs in old age, can promote selection for adaptive mutations and cancer initiation. (vi) Why differential maintenance of stem cell fitness may explain how different vertebrate species with enormous differences in life span and body size similarly avoid cancer through reproductive years.
authors: Department of Biochemistry and Molecular Genetics, Program in Molecular Biology, Integrated Department of Immunology, University of Colorado School of Medicine, Aurora, CO 80045, USA. james.degregori@ucdenver.edu
authors: James
authors: J
authors: DeGregori
references: BMC Biol. 2010 May 21;8:66
references: 20492640
references: Nat Rev Cancer. 2006 Dec;6(12):924-35
references: 17109012
references: Biochim Biophys Acta. 2008 Jan;1785(1):1-11
references: 17980163
references: Front Biosci (Schol Ed). 2011 Jan 01;3:487-500
references: 21196392
references: Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21713-8
references: 21098275
references: Science. 1976 Oct 1;194(4260):23-8
references: 959840
references: Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585-9
references: 1059147
references: Cell Cycle. 2010 Aug 1;9(15):3005-11
references: 20676038
references: Trends Ecol Evol. 2005 Oct;20(10):545-52
references: 16701433
references: Blood. 2009 May 21;113(21):5111-20
references: 19270262
references: Nature. 2004 Nov 18;432(7015):307-15
references: 15549092
references: Genetics. 1931 Mar;16(2):97-159
references: 17246615
references: Bioessays. 2009 Apr;31(4):478-86
references: 19274660
references: Bioessays. 2004 Mar;26(3):291-9
references: 14988930
references: Blood. 2005 May 1;105(9):3465-71
references: 15644418
references: Nat Rev Cancer. 2002 May;2(5):331-41
references: 12044009
references: PLoS Biol. 2005 Dec;3(12):e401
references: 16277552
references: Nat Rev Cancer. 2007 Mar;7(3):213-21
references: 17301845
references: Cell Stem Cell. 2010 Apr 2;6(4):309-22
references: 20362536
references: Nat Rev Cancer. 2010 Aug;10(8):526-7
references: 21137109
references: Trends Ecol Evol. 2011 Apr;26(4):175-82
references: 21296451
references: Cancer Res. 2009 Sep 15;69(18):7262-9
references: 19738065
references: Nat Rev Cancer. 2003 Mar;3(3):226-31
references: 12612657
references: Evolution. 2003 May;57(5):939-48
references: 12836813
references: Cell. 2005 Feb 25;120(4):437-47
references: 15734677
references: Bioessays. 2003 Nov;25(11):1035-9
references: 14579244
references: PLoS Comput Biol. 2007 Dec;3(12):e250
references: 18085819
references: Nat Rev Cancer. 2008 Jan;8(1):56-61
references: 18059462
references: Semin Cancer Biol. 2008 Oct;18(5):322-9
references: 18456510
references: Annu Rev Genet. 1990;24:305-26
references: 2088171
references: Nature. 2010 Aug 5;466(7307):720-6
references: 20686567
references: PLoS Biol. 2010 Mar 02;8(3):e1000324
references: 20208998
references: Differentiation. 2002 Dec;70(9-10):537-46
references: 12492495
references: Nature. 2000 Nov 9;408(6809):248-54
references: 11089982
references: J Clin Invest. 2007 Nov;117(11):3283-95
references: 17960249
references: Nature. 1975 May 15;255(5505):197-200
references: 1143315